Given that blood samples from patients with obesity were not consistently collected on days 3–5 of the menstrual cycle, an objective comparison of FSH, LH, and estradiol hormone levels was not possible due to their cycle sensitivity. This evidence concerns the gene BRD2 and obesity due to melanocortin 4 receptor deficiency.